Monografie
Immunotherapy of Prostate Carcinoma with biodegradable PLGA Microspheres
- Sprache
-
Englisch
- Identifier
-
1115726641
- Thema
-
Krebs; Onkologie; Hochschulschrift
- Beteiligte Personen und Organisationen
-
Herrmann, Valerie Laura
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:54 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Monografie
Beteiligte
- Herrmann, Valerie Laura
Ähnliche Objekte (12)
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Tumor eradication by immunotherapy with biodegradable PLGA microspheres : an alternative to incomplete Freund's adjuvant
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma
Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer
Carcinoma of the prostate : innovations in management
Development and Characterization of a novel Immunotherapy against Prostate Cancer
CpG-DNA – a potential adjuvant in prostate cancer immunotherapy
CpG-DNA : a potential adjuvant in prostate cancer immunotherapy
V domain of RAGE interacts with AGEs on prostate carcinoma cells
Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP mice
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy
Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Tumor eradication by immunotherapy with biodegradable PLGA microspheres : an alternative to incomplete Freund's adjuvant
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma
Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer
Carcinoma of the prostate : innovations in management
Development and Characterization of a novel Immunotherapy against Prostate Cancer
CpG-DNA – a potential adjuvant in prostate cancer immunotherapy
CpG-DNA : a potential adjuvant in prostate cancer immunotherapy
V domain of RAGE interacts with AGEs on prostate carcinoma cells
Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP mice
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy
Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Tumor eradication by immunotherapy with biodegradable PLGA microspheres : an alternative to incomplete Freund's adjuvant
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma
Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer
Carcinoma of the prostate : innovations in management
Development and Characterization of a novel Immunotherapy against Prostate Cancer
CpG-DNA – a potential adjuvant in prostate cancer immunotherapy
CpG-DNA : a potential adjuvant in prostate cancer immunotherapy
V domain of RAGE interacts with AGEs on prostate carcinoma cells
Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP mice
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy